Jelena M. Janjic, Ph.D. - Publications

Pharmaceutical Sciences Duquesne University, Pittsburgh, PA, United States 
theranostic nanoparticles

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Adena SKR, Herneisey M, Pierce E, Hartmeier PR, Adlakha S, Hosfeld MAI, Drennen JK, Janjic JM. Quality by Design Methodology Applied to Process Optimization and Scale up of Curcumin Nanoemulsions Produced by Catastrophic Phase Inversion. Pharmaceutics. 13. PMID 34203672 DOI: 10.3390/pharmaceutics13060880  1
2021 Lambert E, Janjic JM. Quality by design approach identifies critical parameters driving oxygen delivery performance in vitro for perfluorocarbon based artificial oxygen carriers. Scientific Reports. 11: 5569. PMID 33692373 DOI: 10.1038/s41598-021-84076-1  1
2020 Herneisey M, Salcedo PF, Domenech T, Bagia C, George SS, Tunney R, Velankar S, Hitchens TK, Janjic JM. Design of Thermoresponsive Polyamine Cross-Linked Perfluoropolyether Hydrogels for Imaging and Delivery Applications. Acs Medicinal Chemistry Letters. 11: 2032-2040. PMID 33062189 DOI: 10.1021/Acsmedchemlett.0C00198  1
2020 Liu L, Karagoz H, Herneisey M, Zor F, Komatsu T, Loftus S, Janjic BM, Gorantla VS, Janjic JM. Sex Differences Revealed in a Mouse CFA Inflammation Model with Macrophage Targeted Nanotheranostics. Theranostics. 10: 1694-1707. PMID 32042330 DOI: 10.7150/thno.41309  1
2019 Janjic JM, Gorantla VS. Nanomedicine in organ transplantation and regenerative surgery: an interview with Vijay Gorantla and Jelena Janjic. Nanomedicine (London, England). PMID 31833802 DOI: 10.2217/nnm-2019-0423  1
2019 Zor F, Karagoz H, Kapucu H, Kulahci Y, Janjic JM, Gorantla VS. Immunological considerations and concerns as pertinent to whole eye transplantation. Current Opinion in Organ Transplantation. 24: 726-732. PMID 31689262 DOI: 10.1097/MOT.0000000000000713  1
2019 Janjic JM, Gorantla VS. Nanomedicine: new hope for transplant paradigms lost? Nanomedicine (London, England). PMID 31674278 DOI: 10.2217/nnm-2019-0338  1
2019 Stevens AM, Liu L, Bertovich D, Janjic JM, Pollock JA. Differential Expression of Neuroinflammatory mRNAs in the Rat Sciatic Nerve Following Chronic Constriction Injury and Pain-Relieving Nanoemulsion NSAID Delivery to Infiltrating Macrophages. International Journal of Molecular Sciences. 20. PMID 31652890 DOI: 10.3390/ijms20215269  1
2019 Saleem M, Deal B, Nehl E, Janjic JM, Pollock JA. Nanomedicine-driven neuropathic pain relief in a rat model is associated with macrophage polarity and mast cell activation. Acta Neuropathologica Communications. 7: 108. PMID 31277709 DOI: 10.1186/s40478-019-0762-y  1
2019 Herneisey M, Lambert E, Kachel A, Shychuck E, Drennen JK, Janjic JM. Quality by Design Approach Using Multiple Linear and Logistic Regression Modeling Enables Microemulsion Scale Up. Molecules (Basel, Switzerland). 24. PMID 31151246 DOI: 10.3390/Molecules24112066  1
2019 Lambert E, Janjic JM. Multiple Linear Regression Applied to Predicting Droplet Size of Complex Perfluorocarbon Nanoemulsions for Biomedical Applications. Pharmaceutical Development and Technology. 1-36. PMID 30724654 DOI: 10.1080/10837450.2019.1578372  1
2019 Herneisey M, Liu L, Lambert E, Schmitz N, Loftus S, Janjic JM. Development of Theranostic Perfluorocarbon Nanoemulsions as a Model Non-Opioid Pain Nanomedicine Using a Quality by Design (QbD) Approach. Aaps Pharmscitech. 20: 65. PMID 30627887 DOI: 10.1208/s12249-018-1287-6  1
2018 Janjic JM, Vasudeva K, Saleem M, Stevens A, Liu L, Patel S, Pollock JA. Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat. Journal of Neuroimmunology. PMID 29519721 DOI: 10.1016/j.jneuroim.2018.02.010  1
2017 Janjic JM, S Gorantla V. Peripheral Nerve Nanoimaging: Monitoring Treatment and Regeneration. The Aaps Journal. PMID 28779380 DOI: 10.1208/s12248-017-0129-x  0.01
2016 Herneisey M, Williams J, Mirtic J, Liu L, Potdar S, Bagia C, Cavanaugh JE, Janjic JM. Development and characterization of resveratrol nanoemulsions carrying dual-imaging agents. Therapeutic Delivery. PMID 27834615 DOI: 10.4155/Tde-2016-0050  1
2016 Janjic JM, Patel SK, Bagia C. Utilization of Near-Infrared Fluorescent Imaging for Pharmaceutically Relevant Applications. Methods in Molecular Biology (Clifton, N.J.). 1444: 97-108. PMID 27283421 DOI: 10.1007/978-1-4939-3721-9_10  1
2016 Kolber BJ, Janjic JM, Pollock JA, Tidgewell KJ. Summer undergraduate research: A new pipeline for pain clinical practice and research. Bmc Medical Education. 16: 135. PMID 27142616 DOI: 10.1186/S12909-016-0648-7  1
2015 Liu L, Bagia C, Janjic JM. The First Scale-Up Production of Theranostic Nanoemulsions. Bioresearch Open Access. 4: 218-28. PMID 26309798 DOI: 10.1089/biores.2014.0030  1
2015 Vasudeva K, Vodovotz Y, Azhar N, Barclay D, Janjic JM, Pollock JA. In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain. Journal of Neuroimmunology. 283: 43-9. PMID 26004155 DOI: 10.1016/J.Jneuroim.2015.04.012  1
2015 Patel SK, Beaino W, Anderson CJ, Janjic JM. Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. Clinical Immunology (Orlando, Fla.). PMID 25959685 DOI: 10.1016/j.clim.2015.04.019  1
2015 Patel SK, Janjic JM. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. Theranostics. 5: 150-72. PMID 25553105 DOI: 10.7150/thno.9476  1
2014 Wen Y, Liu W, Bagia C, Zhang S, Bai M, Janjic JM, Giannoukakis N, Gawalt ES, Meng WS. Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells. Acta Biomaterialia. 10: 4759-67. PMID 25117952 DOI: 10.1016/J.Actbio.2014.08.003  1
2014 Mountain GA, Jelier BJ, Bagia C, Friesen CM, Janjic JM. Design and formulation of nanoemulsions using 2-(poly(hexafluoropropylene oxide)) perfluoropropyl benzene in combination with linear perfluoro(polyethylene glycol dimethyl ether). Journal of Fluorine Chemistry. 162: 38-44. PMID 24976645 DOI: 10.1016/J.Jfluchem.2014.03.007  1
2014 Jia N, Zhang S, Shao P, Bagia C, Janjic JM, Ding Y, Bai M. Cannabinoid CB2 receptor as a new phototherapy target for the inhibition of tumor growth. Molecular Pharmaceutics. 11: 1919-29. PMID 24779700 DOI: 10.1021/Mp5001923  1
2014 Janjic JM, Shao P, Zhang S, Yang X, Patel SK, Bai M. Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties. Biomaterials. 35: 4958-68. PMID 24674463 DOI: 10.1016/J.Biomaterials.2014.03.006  1
2014 Vasudeva K, Andersen K, Zeyzus-Johns B, Hitchens TK, Patel SK, Balducci A, Janjic JM, Pollock JA. Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and ¹⁹F magnetic resonance. Plos One. 9: e90589. PMID 24587398 DOI: 10.1371/journal.pone.0090589  1
2013 Patel SK, Williams J, Janjic JM. Cell Labeling for 19F MRI: New and Improved Approach to Perfluorocarbon Nanoemulsion Design. Biosensors. 3: 341-59. PMID 25586263 DOI: 10.3390/bios3030341  1
2013 Patrick MJ, Janjic JM, Teng H, O'Hear MR, Brown CW, Stokum JA, Schmidt BF, Ahrens ET, Waggoner AS. Intracellular pH measurements using perfluorocarbon nanoemulsions. Journal of the American Chemical Society. 135: 18445-57. PMID 24266634 DOI: 10.1021/Ja407573M  1
2013 Patel SK, Patrick MJ, Pollock JA, Janjic JM. Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemuslions. Journal of Biomedical Optics. 18: 101312. PMID 23912666 DOI: 10.1117/1.JBO.18.10.101312  1
2013 Balducci A, Wen Y, Zhang Y, Helfer BM, Hitchens TK, Meng WS, Wesa AK, Janjic JM. A novel probe for the non-invasive detection of tumor-associated inflammation. Oncoimmunology. 2: e23034. PMID 23526711 DOI: 10.4161/onci.23034  1
2013 Patel SK, Zhang Y, Pollock JA, Janjic JM. Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study. Plos One. 8: e55802. PMID 23409048 DOI: 10.1371/journal.pone.0055802  1
2013 Janjic JM, Patel SK, Patrick MJ, Pollock JA, DiVito E, Cascio M. Suppressing inflammation from inside out with novel NIR visible perfluorocarbon nanotheranostics Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8596. DOI: 10.1117/12.2004625  1
2012 O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM. NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. Journal of Fluorine Chemistry. 137: 27-33. PMID 22675234 DOI: 10.1016/j.jfluchem.2012.02.004  1
2011 Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, Ho C. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magnetic Resonance in Medicine. 65: 1144-53. PMID 21305593 DOI: 10.1002/Mrm.22702  1
2010 Kadayakkara DK, Janjic JM, Pusateri LK, Young WB, Ahrens ET. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 64: 1252-9. PMID 20860007 DOI: 10.1002/Mrm.22506  1
2010 Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas. 39: 510-5. PMID 20084048 DOI: 10.1097/Mpa.0B013E3181Bd6501  1
2010 Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, de Vries IJ, Ahrens ET, Mailliard RB. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy. 12: 238-50. PMID 20053146 DOI: 10.3109/14653240903446902  1
2009 Janjic JM, Ahrens ET. Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 1: 492-501. PMID 19920872 DOI: 10.1002/Wnan.35  1
2009 Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific t cells using 19F MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 62: 747-53. PMID 19585593 DOI: 10.1002/Mrm.22063  1
2009 Sarachine MJ, Janjic JM, Wipf P, Day BW. Biphenyl C-cyclopropylalkylamides: New scaffolds for targeting estrogen receptor beta. Bioorganic & Medicinal Chemistry Letters. 19: 2404-8. PMID 19356928 DOI: 10.1016/J.Bmcl.2009.03.075  1
2008 Janjic JM, Srinivas M, Kadayakkara DK, Ahrens ET. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. Journal of the American Chemical Society. 130: 2832-41. PMID 18266363 DOI: 10.1021/Ja077388J  1
2007 Wipf P, Gong H, Janjic JM, Li S, Day BW, Xie W. New opportunities for pregnane X receptor (PXR) targeting in drug development. lessons from Enantio- and species-specific PXR ligands identified from a discovery library of amino acid analogues. Mini Reviews in Medicinal Chemistry. 7: 617-25. PMID 17584160 DOI: 10.2174/138955707780859404  1
2005 Wipf P, Coleman CM, Janjic JM, Iyer PS, Fodor MD, Shafer YA, Stephenson CR, Kendall C, Day BW. Microwave-assisted "libraries from libraries" approach toward the synthesis of allyl- and C-cyclopropylalkylamides. Journal of Combinatorial Chemistry. 7: 322-30. PMID 15762763 DOI: 10.1021/Cc049842A  1
2005 Janjic JM, Mu Y, Kendall C, Stephenson CR, Balachandran R, Raccor BS, Lu Y, Zhu G, Xie W, Wipf P, Day BW. New antiestrogens from a library screen of homoallylic amides, allylic amides, and C-cyclopropylalkylamides. Bioorganic & Medicinal Chemistry. 13: 157-64. PMID 15582460 DOI: 10.1016/J.Bmc.2004.09.048  1
2005 Poloyac SM, Rohan LC, Janjic JM, Gibbs RB, Kroboth PD, Smith RB. Graduate Education and Research at the University of Pittsburgh (GEAR-UP): A program to educate students about pharmaceutical research American Journal of Pharmaceutical Education. 69. DOI: 10.5688/Aj690591  1
2004 Wipf P, Janjic J, Stephenson CR. Microwave-assisted synthesis of allylic amines: considerable rate acceleration in the hydrozirconation-transmetalation-aldimine addition sequence. Organic & Biomolecular Chemistry. 2: 443-5. PMID 14770219 DOI: 10.1039/B316741K  1
2002 Wang Y, Janjic J, Kozmin SA. Synthesis of leucascandrolide A via a spontaneous macrolactolization. Journal of the American Chemical Society. 124: 13670-1. PMID 12431085 DOI: 10.1021/Ja028428G  1
2002 Lu G, Janjic BM, Janjic J, Whiteside TL, Storkus WJ, Vujanovic NL. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-α1β2, Fas ligand, and TNF-related apoptosis-inducing ligand Journal of Immunology. 168: 1831-1839. PMID 11823516 DOI: 10.4049/Jimmunol.168.4.1831  1
Show low-probability matches.